Mateusz Wierzbicki Selected Research

Mateusz Wierzbicki Research Topics

Disease

22	Neoplasms (Cancer) 06/2023 - 01/2011
19	Glioblastoma (Glioblastoma Multiforme) 06/2023 - 01/2011
9	Glioma (Gliomas) 01/2023 - 01/2013
5	Liver Neoplasms (Liver Cancer) 11/2023 - 01/2016
5	Hepatocellular Carcinoma (Hepatoma) 06/2023 - 01/2015
4	Breast Neoplasms (Breast Cancer) 06/2023 - 03/2019
3	Mastitis 01/2024 - 04/2019
3	Brain Neoplasms (Brain Tumor) 10/2017 - 01/2011
2	Adenocarcinoma 11/2021 - 03/2019
2	Necrosis 12/2019 - 01/2013
2	Body Weight (Weight, Body) 10/2016 - 12/2015
1	Inflammation (Inflammations) 11/2023
1	Digital Dermatitis 03/2023
1	Cytokine Release Syndrome 01/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2021
1	Bovine Mastitis 06/2021
1	Colorectal Neoplasms (Colorectal Cancer) 03/2019
1	Drug-Related Side Effects and Adverse Reactions 10/2017
1	Hemolysis 09/2017
1	type 2 alpha 1 Collagenopathy 01/2015

Drug/Important Bio-Agent (IBA)

15	GraphiteIBA 01/2023 - 01/2013
12	graphene oxideIBA 01/2023 - 01/2015
10	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2015
8	DiamondIBA 06/2023 - 01/2015
7	CarbonIBA 11/2021 - 01/2011
3	PlatinumIBA 06/2023 - 10/2017
3	Messenger RNA (mRNA)IBA 01/2023 - 10/2017
3	Interleukin-8 (Interleukin 8)IBA 01/2023 - 10/2018
3	Antineoplastic Agents (Antineoplastics)IBA 08/2022 - 01/2016
3	SilverIBA 06/2021 - 01/2015
3	OxidesIBA 01/2021 - 12/2018
2	fullerene C60IBA 11/2023 - 01/2019
2	Tissue Inhibitor of Metalloproteinase-2IBA 01/2023 - 11/2021
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2023 - 10/2018
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 01/2023 - 11/2021
2	Interleukin-6 (Interleukin 6)IBA 01/2023 - 10/2018
2	CopperIBA 06/2021 - 04/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2018 - 01/2017
2	Cisplatin (Platino)FDA LinkGeneric 10/2017 - 01/2017
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2017 - 01/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Iodine-125IBA 06/2023
1	Therapeutic UsesIBA 06/2023
1	Anti-Infective Agents (Microbicides)IBA 03/2023
1	Trastuzumab (Herceptin)FDA Link 03/2023
1	GoldIBA 03/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2023
1	CytokinesIBA 01/2023
1	FullerenesIBA 01/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 09/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	Melitten (Melittin)IBA 12/2019
1	Bee Venoms (Bee Venom)IBA 12/2019
1	Cytochrome P-450 CYP2C9IBA 12/2019
1	CyclinsIBA 04/2019
1	diazonaphthalenedisulfonic acid (NDS)IBA 04/2019
1	MetalsIBA 04/2019
1	EnzymesIBA 03/2019
1	SaltsIBA 03/2019
1	Bromodeoxyuridine (BrdU)IBA 03/2019
1	Oxygen (Dioxygen)IBA 12/2018
1	Reactive Nitrogen SpeciesIBA 10/2018
1	Transcription Factors (Transcription Factor)IBA 10/2018
1	Caspase 3 (Caspase-3)IBA 10/2017
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	CateninsIBA 01/2017
1	CurcuminIBA 01/2016
1	Arginine (L-Arginine)FDA Link 10/2015
1	Proline (L-Proline)FDA Link 10/2015
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2015

Therapy/Procedure

11	Therapeutics 06/2023 - 01/2013
3	Aftercare (After-Treatment) 01/2023 - 01/2021
1	Complementary Therapies (Alternative Medicine) 06/2021
1	Injections 09/2017
1	Intraperitoneal Injections 12/2015